| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |